Turn Therapeutics, Inc. (TTRX)
12.69
-0.69
(-5.16%)
USD |
NASDAQ |
Sep 11, 16:00
12.69
0.00 (0.00%)
After-Hours: 04:39
Turn Therapeutics Enterprise Value : 373.84M for Sept. 11, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 373.84M |
| September 10, 2026 | 394.40M |
| September 09, 2026 | 405.42M |
| September 08, 2026 | 372.95M |
| September 04, 2026 | 287.75M |
| September 03, 2026 | 295.80M |
| September 02, 2026 | 283.88M |
| September 01, 2026 | 288.35M |
| August 31, 2026 | 281.80M |
| August 28, 2026 | 288.95M |
| August 27, 2026 | 296.99M |
| August 26, 2026 | 282.69M |
| August 25, 2026 | 285.67M |
| August 24, 2026 | 284.18M |
| August 21, 2026 | 277.63M |
| August 20, 2026 | 280.01M |
| August 19, 2026 | 288.35M |
| August 18, 2026 | 293.41M |
| August 17, 2026 | 291.03M |
| August 14, 2026 | 280.90M |
| August 13, 2026 | 289.54M |
| August 12, 2026 | 309.80M |
| August 11, 2026 | 300.27M |
| August 10, 2026 | 281.80M |
| August 07, 2026 | 305.93M |
| Date | Value |
|---|---|
| August 06, 2026 | 282.10M |
| August 05, 2026 | 276.73M |
| August 04, 2026 | 279.41M |
| August 03, 2026 | 259.16M |
| July 31, 2026 | 244.86M |
| July 30, 2026 | 241.58M |
| July 29, 2026 | 217.16M |
| July 28, 2026 | 225.20M |
| July 27, 2026 | 227.58M |
| July 24, 2026 | 250.22M |
| July 23, 2026 | 278.22M |
| July 22, 2026 | 282.39M |
| July 21, 2026 | 299.07M |
| July 20, 2026 | 295.20M |
| July 17, 2026 | 267.50M |
| July 16, 2026 | 264.82M |
| July 15, 2026 | 281.20M |
| July 14, 2026 | 282.99M |
| July 13, 2026 | 277.92M |
| July 10, 2026 | 277.03M |
| July 09, 2026 | 258.26M |
| July 08, 2026 | 269.58M |
| July 07, 2026 | 285.07M |
| July 06, 2026 | 224.90M |
| July 02, 2026 | 207.92M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| ANI Pharmaceuticals, Inc. | 1.847B |
| Corcept Therapeutics, Inc. | 11.87B |
| Veru, Inc. | 18.49M |
| Johnson & Johnson | 667.86B |
| Eli Lilly & Co. | 1.096T |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -5.850M |
| Total Expenses (Quarterly) | 5.850M |
| EPS Diluted (Quarterly) | -0.1964 |
| Earnings Yield | -2.27% |
| Normalized Earnings Yield | -2.333 |